Amvisc

Drug overview for AMVISC (hyaluronate sodium):

Generic name: HYALURONATE SODIUM
Drug class: Visco-Elastics, Intraocular
Therapeutic class: Ophthalmic Agents

No enhanced Introduction information available for this drug.

No enhanced Uses information available for this drug.

DRUG IMAGES

AMVISC 1.2% SYRINGE

The following indications for AMVISC (hyaluronate sodium) have been approved by the FDA:

Indications:
None.

Professional Synonyms:
None.

The following dosing information is available for AMVISC (hyaluronate sodium):

Dosing
Administration
Dosing Information
Generic

No enhanced Dosing information available for this drug.

No enhanced Administration information available for this drug.

No dosing information available.

No generic dosing information available.

The following drug interaction information is available for AMVISC (hyaluronate sodium):

Contraindicated
Severe
Moderate

There are 0 contraindications.

There are 0 severe interactions.

There are 0 moderate interactions.

The following contraindication information is available for AMVISC (hyaluronate sodium):

Overview
Contraindicated
Severe
Moderate

Drug contraindication overview.

No enhanced Contraindications information available for this drug.

There are 0 contraindications.

There are 0 severe contraindications.

There are 1 moderate contraindications. Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.

Moderate List
Glaucoma

The following adverse reaction information is available for AMVISC (hyaluronate sodium):

Overview
Severe
Less Severe

Adverse reaction overview.

No enhanced Common Adverse Effects information available for this drug.

There are 4 severe adverse reactions.

More Frequent	Less Frequent
None.	Ocular hypertension

Rare/Very Rare
Corneal degeneration Hypopyon Iritis

There are 1 less severe adverse reactions.

More Frequent	Less Frequent
None.	Corneal edema

Rare/Very Rare
None.

The following precautions are available for AMVISC (hyaluronate sodium):

Pediatric
Pregnant
Lactation
Geriatric

No enhanced Pediatric Use information available for this drug.

Contraindicated

None

Severe Precaution

None

Management or Monitoring Precaution

None

No enhanced Pregnancy information available for this drug.

No enhanced Lactation information available for this drug.

No enhanced Geriatric Use information available for this drug.

The following prioritized warning is available for AMVISC (hyaluronate sodium):

No warning message for this drug.

The following icd codes are available for AMVISC (hyaluronate sodium)'s list of indications:

No ICD codes found for this drug.